BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.

Blood
Naoko TsuyamaKengo Takeuchi

Abstract

Overexpression of the BCL2 is associated with a poor prognosis in diffuse large B-cell lymphoma (DLBCL). The assessment of MYC immunohistochemistry (IHC) is becoming optimized, whereas the criteria for BCL2 positivity are highly variable. Furthermore, data on the frequency and prognostic value of BCL2 positivity are conflicting. We aimed to evaluate BCL2 expression by IHC and assess the prognostic significance of the histopathologically scored BCL2 expression in 456 patients with DLBCL uniformly treated with standard immunochemotherapy (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone, R-CHOP). We initially designed 4-grade BCL2 scoring criteria, from 0 to 3+, and found that ∼40% of DLBCL showed strong BCL2 expression (score 3+). The scores from the pathologist's visual estimation were confirmed to be reliable using a digital image analysis. A retrospective survival analysis revealed that BCL2 score 3+ was a significant prognostic factor independent of the international prognostic index (IPI), the IHC-determined cell of origin, and the MYC protein/rearrangement status in a training set (n = 218). The adverse prognostic impact of BCL2 score 3+ was confirmed in a validation set (n = 238). We also develope...Continue Reading

References

Jun 21, 1985·Science·Y TsujimotoC M Croce
Jul 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M H KramerP M Kluin
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Oct 3, 2002·Nature Reviews. Cancer·Stella PelengarisGerard Evan
Nov 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert L CampDavid L Rimm
Sep 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pascale De PaepeChris De Wolf-Peeters
Jan 19, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Javeed IqbalWing C Chan
Mar 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daphne de JongUNKNOWN Lunenburg Lymphoma Biomarker Consortium
Jul 29, 2011·Nature·Ryan D MorinMarco A Marra
Sep 22, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Javeed IqbalWing C Chan
Dec 23, 2011·Leukemia·J M SchuetzR D Gascoyne
Feb 9, 2012·The American Journal of Surgical Pathology·Tina Marie GreenMichael Boe Møller
Apr 19, 2012·PloS One·Michael J KlukScott J Rodig
Jun 6, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tina Marie GreenMichael Boe Møller
Aug 2, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nathalie A JohnsonRandy D Gascoyne
Jan 22, 2013·Blood·Heike HornUNKNOWN German High-Grade Non-Hodgkin Lymphoma Study Group
Dec 21, 2013·Nature Reviews. Molecular Cell Biology·Peter E CzabotarJerry M Adams
Feb 11, 2014·British Journal of Haematology·Anamarija M PerryDennis D Weisenburger
Nov 29, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Amer Z MahmoudMohammad A Vasef
Mar 26, 2015·Seminars in Hematology·Kennosuke Karube, Elias Campo
Aug 5, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W ScottRandy D Gascoyne
Oct 16, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Magdalena KlanovaPavel Klener
Dec 8, 2015·The New England Journal of Medicine·Andrew W RobertsJohn F Seymour
Jan 30, 2016·Nature Reviews. Cancer·Alex R D DelbridgeDavid L Vaux
Feb 3, 2016·American Journal of Clinical Pathology·Michael J KlukScott J Rodig

❮ Previous
Next ❯

Citations

Sep 13, 2019·Expert Review of Hematology·R Andrew HarkinsJean L Koff
Aug 31, 2019·British Journal of Haematology·Laure PhilippeUNKNOWN ANRS-CO16 LYMPHOVIR Cohort
Jan 24, 2019·Frontiers in Oncology·Clare M AdamsChristine M Eischen
Jun 18, 2020·Leukemia & Lymphoma·Susanne Bram EdnerssonPer-Ola Andersson
Jul 25, 2019·Journal of Clinical Medicine·Julie DevinCaroline Bret
Jul 19, 2020·Journal of Clinical Pathology·Kate DinneenRichard Flavin
Nov 9, 2018·Proceedings of the National Academy of Sciences of the United States of America·Yuxuan LiuAnas Younes
Dec 12, 2020·Clinical Lymphoma, Myeloma & Leukemia·Elizabeth PunnooseUmberto Vitolo
May 5, 2021·Biochimica Et Biophysica Acta. Molecular Cell Research·Gabriel PradoRichard L Bennett
May 21, 2021·Biochimica Et Biophysica Acta. Reviews on Cancer·Linlin ZhangXiangxuan Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sharon BarransAndrew Jack
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Nathalie A JohnsonRandy D Gascoyne
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Christiane Copie-BergmanThierry J Molina
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jack PhanBouthaina Shbib Dabaja
© 2022 Meta ULC. All rights reserved